{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T12:36:54Z","timestamp":1765370214447,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T00:00:00Z","timestamp":1688774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s10072-023-06944-0","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T11:02:22Z","timestamp":1688814142000},"page":"2995-2998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Progressive multifocal leukoencephalopathy in multiple myeloma: a case report of a patient with SARS-CoV-2 infection and an updated systematic literature review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5347-378X","authenticated-orcid":false,"given":"Matteo","family":"Paolucci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0311-0630","authenticated-orcid":false,"given":"Luana","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-8868","authenticated-orcid":false,"given":"Mauro","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Borghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6449-8969","authenticated-orcid":false,"given":"Elena","family":"Merli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Marchionni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Galluzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Cilloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Simonetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1486-4507","authenticated-orcid":false,"given":"Andrea","family":"Zini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,8]]},"reference":[{"key":"6944_CR1","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00415-021-10952-5","volume":"269","author":"N M\u00f6hn","year":"2022","unstructured":"M\u00f6hn N, Grote-Levi L, Hopfner F et al (2022) Innovative therapeutic concepts of progressive multifocal leukoencephalopathy. J Neurol 269:2403\u20132413","journal-title":"J Neurol"},{"key":"6944_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00277-020-04294-x","volume":"100","author":"I Koutsavlis","year":"2021","unstructured":"Koutsavlis I (2021) Progressive multifocal leukoencephalopathy in multiple myeloma. A literature review and lessons to learn. Ann Hematol 100:1\u201310","journal-title":"Ann Hematol"},{"key":"6944_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/1756285615602832","volume":"8","author":"D Pavlovic","year":"2015","unstructured":"Pavlovic D, Patera AC, Nyberg F, Gerber M, Liu M, Consortium PML (2015) Progressive multifocal leukoencephalopathy: current treatment options and future perspectives. Ther Adv Neurol Diso 8:255\u2013273","journal-title":"Ther Adv Neurol Diso"},{"key":"6944_CR4","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","volume":"80","author":"JR Berger","year":"2013","unstructured":"Berger JR, Aksamit AJ, Clifford DB et al (2013) PML diagnostic criteria. Neurology 80:1430\u20131438","journal-title":"Neurology"},{"key":"6944_CR5","doi-asserted-by":"crossref","unstructured":"Usui Y, Nakano H, Komatsu J et al (2020) Progressive multifocal leukoencephalopathy during treatment with lenalidomide and elotuzumab for multiple myeloma. Leukemia Lymphoma 61:2234\u20132237. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2005043758&from=export. Accessed 1 Nov 2022","DOI":"10.1080\/10428194.2020.1765237"},{"key":"6944_CR6","doi-asserted-by":"crossref","unstructured":"Nishimura K, Iwai Y, Yabuki M et al (2021) Lenalidomide-associated progressive multifocal leukoencephalopathy. Clin Exp Neuroimmunol 12:63\u201365. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2005741931&from=export. Accessed 1 Nov 2022","DOI":"10.1111\/cen3.12606"},{"key":"6944_CR7","doi-asserted-by":"crossref","unstructured":"Caracciolo NG, Clemente LD, Galizia P et al (2021) Progressive multifocal leukoencephalopathy after daratumumab in multiple myeloma: a case report. J Neurol Sci 429:118916. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2014980170&from=export. Accessed 1 Nov 2022","DOI":"10.1016\/j.jns.2021.118916"},{"key":"6944_CR8","doi-asserted-by":"crossref","unstructured":"Borgo RM, Palmieri S, Cirillo M et al (2021) Progressive multifocal leukoencephalopathy after immunochemotherapy with DRD protocol for multiple myeloma: a case report. J Neurol Sci 429:118929. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2014981860&from=export. Accessed 1 Nov 2022","DOI":"10.1016\/j.jns.2021.118929"},{"key":"6944_CR9","doi-asserted-by":"crossref","unstructured":"De La Torre A, Gao A, Krings T, Reece DE (2021) Progressive multifocal leukoencephalopathy in multiple myeloma: a single institution case series. In: 63rd ASH Annual Meeting Abstracts, pp 4736\u20134736. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2016087853&from=export. Accessed 1 Nov 2022","DOI":"10.1182\/blood-2021-152895"},{"key":"6944_CR10","doi-asserted-by":"crossref","unstructured":"Burn SC, Kalro A (2021) Progressive multifocal leukoencephalopathy: a complication of prolonged immunosuppression for plasma cell myeloma. Med J Australia 215:454\u2013455. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2014009375&from=export. Accessed 1 Nov 2022","DOI":"10.5694\/mja2.51315"},{"key":"6944_CR11","doi-asserted-by":"crossref","unstructured":"Fernandes P, Bennett K, Storrar N, Johnson P (2022) 164 Progressive multifocal leukoencephalopathy (PML) following autologous peripheral blood stem cell transplantation for multiple myeloma. In: ABN 2022:A60.2\u2013A6A60. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L638392714&from=export. Accessed 1 Nov 2022","DOI":"10.1136\/jnnp-2022-ABN.193"},{"key":"6944_CR12","doi-asserted-by":"crossref","unstructured":"Seko K, Uchida Y, Kanamori T et al (2022) Progressive multifocal leukoencephalopathy in multiple myeloma associated with daratumumab, lenalidomide, and dexamethasone. Neurology Clin Neurosci 10:163\u2013166. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L2015071053&from=export. Accessed 1 Nov 2022","DOI":"10.1111\/ncn3.12586"},{"key":"6944_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/ejh.13909","volume":"110","author":"BW Hoeynck","year":"2023","unstructured":"Hoeynck BW, Cohen AD, Stadtmauer EA et al (2023) Progressive multifocal leukoencephalopathy in multiple myeloma. Eur J Haematol 110:322\u2013329","journal-title":"Eur J Haematol"},{"key":"6944_CR14","first-page":"e4716","volume":"11","author":"A Hussain","year":"2019","unstructured":"Hussain A, Almenfi HF, Almehdewi AM, Hamza MS, Bhat MS, Vijayashankar NP (2019) Laboratory features of newly diagnosed multiple myeloma patients. Cureus 11:e4716","journal-title":"Cureus"},{"key":"6944_CR15","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1093\/qjmed\/hcu094","volume":"107","author":"M Makatsori","year":"2014","unstructured":"Makatsori M, Kiani-Alikhan S, Manson AL et al (2014) Hypogammaglobulinaemia after rituximab treatment\u2014incidence and outcomes. Qjm Int J Med 107:821\u2013828","journal-title":"Qjm Int J Med"},{"key":"6944_CR16","first-page":"472","volume":"68","author":"DL Hamilos","year":"1992","unstructured":"Hamilos DL, Young RM, Peter JB, Agopian MS, Ikl\u00e9 DN, Barka N (1992) Hypogammaglobulinemia in asthmatic patients. Ann Allergy 68:472\u2013481","journal-title":"Ann Allergy"},{"key":"6944_CR17","doi-asserted-by":"publisher","first-page":"632399","DOI":"10.3389\/fimmu.2021.632399","volume":"12","author":"C D\u2019Souza","year":"2021","unstructured":"D\u2019Souza C, Prince HM, Neeson PJ (2021) Understanding the role of T-cells in the antimyeloma effect of immunomodulatory drugs. Front Immunol 12:632399","journal-title":"Front Immunol"},{"key":"6944_CR18","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/art.1780290305","volume":"29","author":"P Newton","year":"1986","unstructured":"Newton P, Aldridge RD, Lessells AM, Best PV (1986) Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus. Arthritis Rheumatism 29:337\u2013343","journal-title":"Arthritis Rheumatism"},{"key":"6944_CR19","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13365-021-00980-2","volume":"27","author":"S Borrelli","year":"2021","unstructured":"Borrelli S, Dachy B, Gazagnes M-D, Pasquier RD (2021) Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia. J Neurovirol 27:510\u2013513","journal-title":"J Neurovirol"},{"key":"6944_CR20","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W et al (2020) Clinical and immunologic features in severe and moderate Coronavirus Disease 2019. J Clin Invest 130:2620\u20132629","journal-title":"J Clin Invest"},{"key":"6944_CR21","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20:363\u2013374","journal-title":"Nat Rev Immunol"},{"key":"6944_CR22","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/S2352-3026(21)00167-8","volume":"8","author":"CL Bennett","year":"2021","unstructured":"Bennett CL, Focosi D, Socal MP et al (2021) Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. Lancet Haematol 8:e593\u2013e604","journal-title":"Lancet Haematol"},{"key":"6944_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jneuroim.2017.05.006","volume":"309","author":"A Carotenuto","year":"2017","unstructured":"Carotenuto A, Scalia G, Ausiello F et al (2017) CD4\/CD8 ratio during natalizumab treatment in multiple sclerosis patients. J Neuroimmunol 309:47\u201350","journal-title":"J Neuroimmunol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-023-06944-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-023-06944-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T06:50:00Z","timestamp":1691650200000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-023-06944-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,8]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["6944"],"URL":"https:\/\/doi.org\/10.1007\/s10072-023-06944-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2023,7,8]]},"assertion":[{"value":"23 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent has been obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}